Ushbu ish iqtibos qilgan ishlar
189 ta ish
Ish: Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi, Siok‐Keen Tey, Gianpietro Dotti +17
MaqolaOchiq kirish20112 iqtibosABIMesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus +9
MaqolaOchiq kirish20132 iqtibosABIOncolytic Viruses: Exploiting Cancer's Deal with the Devil
Larissa A. Pikor, John C. Bell, Jean‐Simon Diallo
Sharh maqola20152 iqtibosABIHarnessing the immune system to improve cancer therapy
Nikos E. Papaioannou, Ourania V. Beniata, Panagiotis Vitsos +2
Sharh maqolaOchiq kirish20162 iqtibosABIElotuzumab: the first approved monoclonal antibody for multiple myeloma treatment
Sharh maqolaOchiq kirish20162 iqtibosABIDaratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
Larysa Sanchez, Yucai Wang, David S. Siegel +1
Sharh maqolaOchiq kirish20162 iqtibosABIOverall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González +30
MaqolaOchiq kirish20172 iqtibosABITumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo‐Jack, Alice T. Shaw
Sharh maqola20172 iqtibosABIInterferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flávia Castro, Ana Patrícia Cardoso, Raquel M. Gonçalves +2
Sharh maqolaOchiq kirish20182 iqtibosABISTT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
Jung-Mao Hsu, Weiya Xia, Yi‐Hsin Elsa Hsu +14
MaqolaOchiq kirish20182 iqtibosABIMetformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong‐Ho Cha, Wenhao Yang, Weiya Xia +25
MaqolaOchiq kirish20182 iqtibosABIRole of the immunosuppressive microenvironment in immunotherapy
Garth W. Tormoen, Marka R. Crittenden, Michael J. Gough
Sharh maqolaOchiq kirish20182 iqtibosABIMechanisms of immunotherapy resistance: lessons from glioblastoma
Christopher M. Jackson, John Choi, Michael Lim
Sharh maqola20192 iqtibosABI